Maven Inc&Grwth 5 - Director/PDMR Shareholding

Maven Income and Growth VCT 5

15/04/2025 09:32

RNS Number : 0875F

Maven Income and Growth VCT 5 PLC

15 April 2025

 

Maven Income and Growth VCT 5 PLC ("the Company")

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Brian Phillips
2
Reason for the notification
a)
Position/status
Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Maven Income and Growth VCT 5 PLC
b)
LEI
213800DMF84841RMWX35
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Ordinary Shares of 10p each
MIG5
b)
Nature of the transaction
Market Purchase
c)
Price(s) and volume(s)
Price(s)
Volume(s)
30.00p
72,500
d)
Aggregated information
- Aggregated volume
- Price
72,500 Ordinary Shares of 10p each
30.00p
e)
Date of the transaction
11 April 2025
f)
Place of the transaction
London
g)
Name of contact and telephone number for queries
Mandy Kelly, Maven Capital Partners UK LLP
Company Secretary (Tel: 0141 306 7400)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHSFSSAIEISEDL